ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

DrugsSubscribe to Drugs

Drug Price Control in India

Price control of life-saving essential medicines is the need of the hour, but the National Pharmaceutical Pricing Authority has allowed a hike of 10% in nearly 800 drugs and devices listed under the National List of Essential Medicines from 1 April 2022 because of the rising input costs. Prices of scheduled drugs are allowed an increase each year acc­ording to the wholesale price index. Input costs are rising primarily because India is heavily dependent on China for drug imports.

The Generic Manoeuvre

The unsound argument in favour of prescription of medicines in their so-called generic version as a panacea for drug price reduction is discursive in nature and, hence, untenable. Such a recommendation by the Prime Minister of India may discount the drug cartel on account of their unethical trade practices, while disowning the government’s responsibility towards effective drug price control.

Punjab’s Drug Problem

Younger persons have been the worst sufferers of the illicit drugs trade in Punjab. Although contrabands have spread their tentacles in all parts, the scourge of drugs has been concentrated in certain localities, clusters, and villages. The demand for illicit drugs in Punjab is largely met from outside the state through a supply network controlled by the local, interstate, and international drug traffi ckers.

How Not to Modernise Alternative Medicine Systems

The implications of the Maharashtra government's permission to homeopathic practitioners to prescribe allopathic drugs are manifold. This form of "modernisation" not only threatens the identity of the alternative systems but also hampers their most important characteristic, namely, healing, which has helped most of the medical systems to stand the test of time.

Back to Top